Literature DB >> 18446308

Identification of internuclear ophthalmoplegia signs in multiple sclerosis patients. Saccade test analysis.

Magdalena Jozefowicz-Korczynska1, Marek Lukomski, Anna Pajor.   

Abstract

BACKGROUND AND
PURPOSE: Patients with multiple sclerosis (MS), due to the diverse nature of the disease, have many types of eye movement disorders, particularly internuclear ophthalmoplegia (INO). The aim of the study was to evaluate the usefulness of a quantitative statistical saccade test analysis for identification of INO in MS patients.
METHODS: Sixty MS patients and 50 volunteers underwent clinical bedside ocularmotor examination and electrooculographic evaluation in a tertiary referral university hospital. Simultaneous electro-oculography recordings of each eye separately were made. In the saccade test, the versional dysconjugacy index (VDI) for saccades velocity and the Z score analysis were applied.
RESULTS: Clinical eye movements disorders were found in 32% of patients. In the MS patients saccades velocity was significantly lower compared with the control group. Based on the results of the control group, we established the cut off values for VDI (1.04) and corresponded Z score (4.46) as the criterion indicated the presence of INO signs in MS patients. We confirmed clinical evidence of different degrees of INO in 15% of patients, and found subclinical INO signs in 20% of patients.
CONCLUSION: The EOG registration is a sensitive electrophysiological method for detecting subtle deficits of ocular motility. Saccade test analysis with calculation of the VDI and the Z-test score is a valuable method for identifying subclinical INO signs in MS patients.

Entities:  

Mesh:

Year:  2008        PMID: 18446308     DOI: 10.1007/s00415-008-0819-5

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  12 in total

1.  Keeping an eye on MS.

Authors:  R J Leigh; J S Wolinsky
Journal:  Neurology       Date:  2001-09-11       Impact factor: 9.910

2.  Saccadic and vestibular abnormalities in multiple sclerosis: sensitive clinical signs of brainstem and cerebellar involvement.

Authors:  Deborah L Downey; John S Stahl; Roongroj Bhidayasiri; Joy Derwenskus; Nancy L Adams; Robert L Ruff; R John Leigh
Journal:  Ann N Y Acad Sci       Date:  2002-04       Impact factor: 5.691

Review 3.  The ocular manifestations of multiple sclerosis. 2. Abnormalities of eye movements.

Authors:  D Barnes; W I McDonald
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-10       Impact factor: 10.154

4.  Saccade metrics in multiple sclerosis: versional velocity disconjugacy as the best clue?

Authors:  J Ventre; A Vighetto; G Bailly; C Prablanc
Journal:  J Neurol Sci       Date:  1991-04       Impact factor: 3.181

5.  Binocular saccadic eye movements in multiple sclerosis.

Authors:  J P Flipse; C S Straathof; J Van der Steen; A F Van Leeuwen; P A Van Doorn; F G Van der Meché; H Collewijn
Journal:  J Neurol Sci       Date:  1997-05-01       Impact factor: 3.181

6.  Abnormal eye movements predict disability in MS: two-year follow-up.

Authors:  Joy Derwenskus; Janet C Rucker; Alessandro Serra; John S Stahl; Deborah L Downey; Nancy L Adams; R John Leigh
Journal:  Ann N Y Acad Sci       Date:  2005-04       Impact factor: 5.691

7.  Quantitative oculographic characterisation of internuclear ophthalmoparesis in multiple sclerosis: the versional dysconjugacy index Z score.

Authors:  E M Frohman; T C Frohman; P O'Suilleabhain; H Zhang; K Hawker; M K Racke; W Frawley; J T Phillips; P D Kramer
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-07       Impact factor: 10.154

8.  [Dissociated nystagmus in side gaze. Major symptoms in the diagnosis of an internuclear ophthalmoplegia].

Authors:  P Neugebauer; A Neugebauer; J Fricke; O Michel
Journal:  HNO       Date:  2004-07       Impact factor: 1.284

9.  The clinical spectrum of internuclear ophthalmoplegia in multiple sclerosis.

Authors:  R M Müri; O Meienberg
Journal:  Arch Neurol       Date:  1985-09

10.  Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis.

Authors:  W I McDonald; A Compston; G Edan; D Goodkin; H P Hartung; F D Lublin; H F McFarland; D W Paty; C H Polman; S C Reingold; M Sandberg-Wollheim; W Sibley; A Thompson; S van den Noort; B Y Weinshenker; J S Wolinsky
Journal:  Ann Neurol       Date:  2001-07       Impact factor: 10.422

View more
  5 in total

1.  Topographic diagnosis of internuclear ophthalmoparesis: evidence from a lesion-behavior mapping study.

Authors:  Bernhard Baier; Frank Thömke; Wibke Müller-Forell; Notger Müller; Marianne Dieterich
Journal:  J Neurol       Date:  2013-05-01       Impact factor: 4.849

2.  Evaluation of the smooth pursuit tests in multiple sclerosis patients.

Authors:  Magdalena Jozefowicz-Korczynska; Anna Maria Pajor
Journal:  J Neurol       Date:  2011-03-29       Impact factor: 4.849

3.  Treatment of internuclear ophthalmoparesis in multiple sclerosis with fampridine: A randomized double-blind, placebo-controlled cross-over trial.

Authors:  Kawita M S Kanhai; Jenny A Nij Bijvank; Yorick L Wagenaar; Erica S Klaassen; KyoungSoo Lim; Sandrin C Bergheanu; Axel Petzold; Ajay Verma; Jacob Hesterman; Mike P Wattjes; Bernard M J Uitdehaag; Laurentius J van Rijn; Geert Jan Groeneveld
Journal:  CNS Neurosci Ther       Date:  2019-02-12       Impact factor: 5.243

4.  Diagnosing and quantifying a common deficit in multiple sclerosis: Internuclear ophthalmoplegia.

Authors:  J A Nij Bijvank; L J van Rijn; L J Balk; H S Tan; B M J Uitdehaag; A Petzold
Journal:  Neurology       Date:  2019-04-19       Impact factor: 9.910

5.  Bedside tested ocular motor disorders in multiple sclerosis patients.

Authors:  G Servillo; D Renard; G Taieb; P Labauge; S Bastide; M Zorzon; G Castelnovo
Journal:  Mult Scler Int       Date:  2014-04-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.